Glatiramer acetate is an immunomodulator drug currently used to treat multiple
sclerosis. It is a random polymer of four amino acids found in myelin basic protein
Mar 15, 2016 ... Glatiramer is used to reduce episodes of symptoms in patients with relapsing-
remitting forms (course of disease where symptoms flare up from ...
Jan 6, 2017 ... Easy to read patient leaflet for glatiramer. Includes indications, proper use,
special instructions, precautions, and possible side effects.
Official site for COPAXONE® (glatiramer acetate injection) from Teva. Includes
use, safety, prescribing information and patient resources.
Glatiramer acetate, the active ingredient of COPAXONE, consists of the acetate
salts of synthetic polypeptides, containing four naturally occurring amino acids: ...
See associated safety information and benefits of COPAXONE® (glatiramer
acetate injection). Find a dosing schedule that may be right for you.
Glatiramer acetate (GA), formerly known as copolymer 1, is a mixture of synthetic
polypeptides composed of four amino acids resembling the myelin basic ...
Jun 19, 2015 ... A generic equivalent of daily Copaxone® (glatiramer acetate, 20 mg), called “
Glatopa”™ (Sandoz, a Novartis company, developed in ...
Jun 10, 2016 ... Consumer information about glatiramer (Copaxone, Glatopa), a multiple sclerosis
(MS) drug prescribed to treat people with relapsing forms of ...
glatiramer acetate injection. FDA provides recommendations for demonstrating
active pharmaceutical ingredient (API) sameness. The Reference Listed Drug ...